Ultragenyx Pharmaceutical (RARE) Total Current Liabilities (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) posted Total Current Liabilities of $351 million for Q2 2026, up 19.7% from $293.24 million a year earlier and up 8.0% from the prior quarter.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Total Current Liabilities (2013 - 2026) Analysis & Trends
At the end of FY2025, Ultragenyx Pharmaceutical's Total Current Liabilities came in at $384 million, up 11.6% from FY2024.
- Annual Total Current Liabilities has increased for four consecutive years, with a five-year compound annual growth rate of 15.2% (FY2020 to FY2025).
- In prior years, Ultragenyx Pharmaceutical's Total Current Liabilities was $344 million in FY2024 (+22.7%), $280.44 million in FY2023 (+7.4%), $261.21 million in FY2022 (+44.0%) and $181.37 million in FY2021 (-4.3%).
- Quarterly Total Current Liabilities has run from a low of $135.93 million in Q3 2021 to a high of $384 million in Q4 2025 over five years.
- On a year-over-year basis, Total Current Liabilities has increased in each of the last 18 quarters, with growth averaging 15.4% over the last eight quarters.
- The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q2 2022, with growth of 73.6%; the weakest was Q3 2021, with a decline of 32.4%.
- According to Business Quant data, Total Current Liabilities for the three prior quarters was $325 million (Q1 2026), $384 million (Q4 2025) and $340.02 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -31.55 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 25.50 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 11.02 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 32.65 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 3.94 Bn |
| 10 | Ultragenyx Pharmaceutical | 1.51 Bn | -292.70 Mn | 180.00 Mn | 351.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 351.00 Mn |
| Mar 31, 2026 | 325.00 Mn |
| Dec 31, 2025 | 384.00 Mn |
| Sep 30, 2025 | 340.02 Mn |
| Jun 30, 2025 | 293.24 Mn |
| Mar 31, 2025 | 291.67 Mn |
| Dec 31, 2024 | 344.00 Mn |
| Sep 30, 2024 | 285.01 Mn |
| Jun 30, 2024 | 272.87 Mn |
| Mar 31, 2024 | 245.58 Mn |
| Dec 31, 2023 | 280.44 Mn |
| Sep 30, 2023 | 253.98 Mn |
| Jun 30, 2023 | 244.38 Mn |
| Mar 31, 2023 | 218.18 Mn |
| Dec 31, 2022 | 261.21 Mn |
| Sep 30, 2022 | 227.36 Mn |
| Jun 30, 2022 | 220.64 Mn |
| Mar 31, 2022 | 167.23 Mn |
| Dec 31, 2021 | 181.37 Mn |
| Sep 30, 2021 | 135.93 Mn |
API Access
Ultragenyx Pharmaceutical Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();